CN105168554A - 一种治疗腮腺炎的药物及其制备方法 - Google Patents
一种治疗腮腺炎的药物及其制备方法 Download PDFInfo
- Publication number
- CN105168554A CN105168554A CN201510572744.5A CN201510572744A CN105168554A CN 105168554 A CN105168554 A CN 105168554A CN 201510572744 A CN201510572744 A CN 201510572744A CN 105168554 A CN105168554 A CN 105168554A
- Authority
- CN
- China
- Prior art keywords
- radix
- gram
- grams
- dries
- dry
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 48
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 229940079593 drug Drugs 0.000 title claims description 19
- 208000005647 Mumps Diseases 0.000 title abstract description 5
- 208000010805 mumps infectious disease Diseases 0.000 title abstract description 5
- 239000010231 banlangen Substances 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 claims description 17
- 241000195474 Sargassum Species 0.000 claims description 17
- 241000255791 Bombyx Species 0.000 claims description 16
- 241000959626 Calvatia Species 0.000 claims description 16
- 239000012535 impurity Substances 0.000 claims description 16
- 238000005202 decontamination Methods 0.000 claims description 14
- 230000003588 decontaminative effect Effects 0.000 claims description 14
- 239000000284 extract Substances 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 6
- 239000002244 precipitate Substances 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 5
- 238000005520 cutting process Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 206010044565 Tremor Diseases 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- 238000010410 dusting Methods 0.000 claims description 2
- 239000000945 filler Substances 0.000 claims description 2
- 239000006260 foam Substances 0.000 claims description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 2
- 235000012907 honey Nutrition 0.000 claims description 2
- 235000011477 liquorice Nutrition 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 235000013599 spices Nutrition 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 230000008961 swelling Effects 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 6
- 240000005528 Arctium lappa Species 0.000 abstract 1
- 235000003130 Arctium lappa Nutrition 0.000 abstract 1
- 235000008078 Arctium minus Nutrition 0.000 abstract 1
- 241000255789 Bombyx mori Species 0.000 abstract 1
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- 241000133231 Marshallia caespitosa Species 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 244000179560 Prunella vulgaris Species 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 235000008113 selfheal Nutrition 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 description 18
- 235000019634 flavors Nutrition 0.000 description 18
- 210000004072 lung Anatomy 0.000 description 16
- 231100000614 poison Toxicity 0.000 description 11
- 239000003440 toxic substance Substances 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 10
- 230000036407 pain Effects 0.000 description 10
- 206010034038 Parotitis Diseases 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 210000003681 parotid gland Anatomy 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 208000033809 Suppuration Diseases 0.000 description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 201000007227 lymph node tuberculosis Diseases 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 210000003026 hypopharynx Anatomy 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 201000000297 Erysipelas Diseases 0.000 description 3
- 208000010201 Exanthema Diseases 0.000 description 3
- 206010018498 Goitre Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010025421 Macule Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 206010042674 Swelling Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 208000002399 aphthous stomatitis Diseases 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 201000005884 exanthem Diseases 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 201000003872 goiter Diseases 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 229940023488 pill Drugs 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 210000000624 ear auricle Anatomy 0.000 description 2
- 206010014599 encephalitis Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 238000009738 saturating Methods 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 206010034023 Parotid gland enlargement Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010072589 Viral parotitis Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 201000011475 meningoencephalitis Diseases 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000003448 neutrophilic effect Effects 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 208000005963 oophoritis Diseases 0.000 description 1
- 229940100691 oral capsule Drugs 0.000 description 1
- 201000005737 orchitis Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 210000003079 salivary gland Anatomy 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗腮腺炎的药物及其制备方法,其主要是由黄芩、黄连、连翘、板蓝根、马勃、牛蒡子、白僵蚕、升麻、柴胡、前胡、薄荷、夏枯草按一定重量配比制备而成,本发明药物具有散风清热,消肿解毒的功能,用于治疗腮腺炎见效快,疗效好,不复发。
Description
技术领域
本发明涉及一种治疗腮腺炎的药物及其制备方法,属中药领域。
背景技术
腮腺是涎液腺中最大的腺体,位于两侧面颊近耳垂处,腮腺肿大以耳垂为中心,可以一侧或两侧;病因为感染性、免疫性、阻塞性及原因未明性炎症肿大等。最常见为感染引起的腮腺炎,多见于细菌性和病毒性。细菌性腮腺炎主要表现为发热、腮腺局部红、肿、热、痛,白细胞计数增多,病变进入化脓期,挤压腮腺可见脓液自导管口流出。病毒性腮腺炎,流行性腮腺炎是由腮腺病毒感染引起的呼吸道传染病,其特征为腮腺的非化脓性肿胀并可侵犯各种腺组织或神经系统及肝、肾、心、关节等几乎所有器官,常可引起脑膜脑炎、睾丸炎、卵巢炎、胰腺炎等并发症,病后可获持久免疫力。目前,由于西药无法有效治疗腮腺炎,因此人们对有效治疗腮腺炎的中药药物存在极大的需求,至今为止,还没有发现关于本发明的有关报道。
发明内容
本发明人依据中医理论的研究和临床试验的反复验证,终于成功找到了有效治疗腮腺炎的药物,从而完成了本发明。
本发明的目的就是提供一种有效治疗腮腺炎的中药组合药物。
本发明的另一目的就是提供了该中药组合药物的制备方法。
本发明药物是选择黄芩、黄连、连翘、玄参、板蓝根、马勃、牛蒡子、白僵蚕、升麻、柴胡、陈皮、桔梗、前胡、甘草、薄荷、夏枯草、海藻、昆布药物进行组合制备的,将这些药物组合使得各药物功效产生协同作用,从而能够有效治疗腮腺炎。
其中选用黄芩是因为其性味苦寒,入心肺、胆、大肠经,有泻实火,除湿热,止血安胎的功能,治壮热烦渴,肺热咳嗽。选用黄连是因为其性味苦,寒,入心、肝、胃、大肠经,有泻火,燥湿,解毒,杀虫的功能,治时行热毒、伤寒,热盛心烦,痞满呕逆,菌痢,热泻腹痛,肺结核,吐、衄、下血,消渴,疳积,蛔虫病,百日咳,咽喉肿痛,火眼,口疮,痈疽疮毒,湿疹,汤火烫伤。选用连翘是因为其性味苦,凉,入心、肝、胆经,有清热,解毒,散结,消肿的功能,治温热,丹毒,斑疹,痈疡肿毒,瘰疬,小便淋闭。选用玄参是因为其性味苦,咸,凉,入肺、肾经,有滋阴,降火,除烦,解毒的功能,治热病烦渴,发斑,骨蒸劳热,夜寐不宁,自汗盗汗,津伤便秘,吐血衄血,咽喉肿痛,痈肿,瘰疬。选用板蓝根是因为其性味苦,寒,入肝、胃血分,有清热,解毒,凉血的功能,治流感,流脑,乙脑,肺炎,丹毒,热毒发斑,神昏吐衄,咽肿,痄腮,火眼,疮疹。选用马勃是因为其性味辛,平。入肺经。清肺利咽,解毒,止血。治喉痹咽痛,咳嗽失音,吐血,衄血,外伤出血。选用牛蒡子是因为其性味辛苦,凉,入肺、胃经,有疏散风热,宣肺透疹,消肿解毒的功能,治风热咳嗽,咽喉肿痛,斑疹不透,风疹作痒,痈肿疮毒。选用白僵蚕是因为其性味辛咸,平,入肝、肺、胃经,有祛风解痉,化痰散结的功能,治中风失音,惊癎,头风,喉风,喉痹,瘰疬结核,风疮瘾疹,丹毒,乳腺炎。选用升麻是因为其性味甘辛微苦,凉,入肺、脾、胃经,有升阳,发表,透疹,解毒的功能,治时气疫劳,头痛寒热,喉痛,口疮疤,斑疹不透,中气下陷,久泻久痢,脱肛,妇女崩带,子宫下坠,痈肿疮毒。选用柴胡是因为其性味苦,凉,入肝、胆经,有和解表里,疏肝,升阳的功能,治寒热往来,胸满胁痛,口苦耳聋,头痛目眩,疟疾,下利脱肛,月经不调,子宫下垂。选用陈皮是因为其性味苦、辛,温,归肺、脾经,有理气健脾,燥湿化痰的功能,治胸脘胀满,食少吐泻,咳嗽痰多。选用桔梗是因为其性味苦辛,平,入肺、胃经,有开宣肺气,祛痰排脓的功能,治外感咳嗽,咽喉肿痛,肺痈吐脓,胸满胁痛,痢疾腹痛。选用前胡是因为其性味辛、苦,微寒,归肺经,有散风清热,降气化痰的功能,治风热咳嗽,痰多,痰热喘满,咯痰黄稠。选用甘草是因为其性味甘平,归脾、胃肺经,有润肺,解毒的功能,炙用治脾胃虚弱,食少,腹痛,便溏,劳倦发热,肺痿咳嗽。选用薄荷是因为其性味辛,凉,入肺、肝经,有疏风,散热,辟秽,解毒的功能,治外感风热,头痛,目赤,咽喉肿痛,食滞气胀,口疮,牙痛,疮疥,瘾疹。选用夏枯草是因为其性味苦辛,寒,入肝、胆经,有清肝,散结的功能,治瘰疬,瘿瘤,乳痈,乳癌,目珠夜痛,羞明流泪,头目眩晕,口眼歪斜,筋骨疼痛,肺结核,急性黄疸型传染性肝炎,血崩,带下。选用海藻是因为其性味苦咸,寒,入肺、脾、肾经,有软坚,消痰,利水,泄热的功能,治瘰疬,瘿瘤,积聚,水肿,脚气,睾丸肿痛。选用昆布是因为其性味咸,寒,入胃经,有软坚,行水的功能,治瘰疬,瘿瘤,噎膈,水肿,睾丸肿痛,带下。
具体实施方式
本发明组分的药物用量也是发明人经过大量摸索总结得出的,各组分的用量在下述重量范围内都具有较好的疗效:
黄芩110-130克、黄连50-70克、连翘140-160克、玄参100-130克、板蓝根250-350克、马勃50-70克、牛蒡子110-130克、白僵蚕80-100克、升麻110-130克、柴胡100-130克、陈皮120-160克、桔梗80-110克、前胡120-160克、甘草80-100克、薄荷120-160克、夏枯草120-160克、海藻115-125克、昆布110-130克。
优选为:
黄芩120克、黄连60克、连翘150克、玄参120克、板蓝根300克、马勃50克、牛蒡子120克、白僵蚕90克、升麻120克、柴胡120克、陈皮150克、桔梗100克、前胡150克、甘草90克、薄荷150克、夏枯草150克、海藻120克、昆布120克。
本发明药物的制备方法如下
一、备料
1、黄芩:拣去杂质,除去残茎,用凉水浸润或置开水中稍浸捞出,切片,晒干;
2、黄连:拣去杂质,洗净泥砂,润透,切片,阴干;
3、连翘:拣净杂质,搓开,除去枝梗;
4、玄参:拣净杂质,除去芦头,洗净润透,切片,晾干;
5、板蓝根:拣净杂质,洗净,润透,切片,晒干;
6、马勃:除去硬皮,切成方块;
7、牛蒡子:拣去杂质,筛去泥屑;
8、白僵蚕:拣去丝毛,洗净灰土,晒干;
9、升麻:拣去杂质,略泡洗净,捞出,润透,切片,晒干;
10、柴胡:拣去杂质,除去残茎,洗净泥沙,捞出,润透后及时切片,晒干;
11、陈皮:取原药材,除去杂质及变黑的果皮,抢水洗净,润软,切丝,晒干或低温干燥,筛去灰屑;
12、桔梗:拣净杂质,除去芦头,洗净捞出,润透后切片,晒干;
13、前胡:取原药材,除去杂质,洗净,润透,切薄片,干燥或低温干燥,筛去碎屑;
14、甘草:取甘草片,加炼熟的蜂蜜与开水少许,拌匀,稍闷,置锅内用文火炒至变深黄色,不粘手为止,取出放凉,每甘草100斤,用炼熟蜂蜜25—30斤;
15、薄荷:拣净杂质,除去残根,先将叶抖下另放,然后将茎喷洒清水,润透后切段,晒干,再与叶和匀;
16、夏枯草:取原药材,除去枝梗、叶片及杂质,筛去灰屑;
17、海藻:拣去杂质,用水略漂,稍晾,切段,晒干;
18、昆布:拣去杂质,用水漂净,切成宽丝,晾干;
二、制备
1、本发明药物胶囊的制备:(1)将炮制好的黄苓、黄连、连翘、玄参、板蓝根、马勃、牛蒡子、白僵蚕、升麻、柴胡、陈皮、桔梗、前胡、甘草、薄荷、夏枯草、海藻、昆布放入煎药容器内加水煎煮二次,第一次加水8倍量,煎煮1.5小时,第二次加水6倍量煎煮1小时,合并两次煎煮液,过滤得滤液;(2)将滤液浓缩成比重为1.35的浸膏,加90%-95%乙醇进行醇沉,回收乙醇并浓缩,在45-50℃下干燥,制得干浸膏;(3)将干浸膏粉碎成粉,装入胶囊,每粒0.5克。
2、本发明药物颗粒剂的制备:
(1)将炮制好的黄苓、黄连、连翘、玄参、板蓝根、马勃、牛蒡子、白僵蚕、升麻、柴胡、陈皮、桔梗、前胡、甘草、薄荷、夏枯草、海藻、昆布放入煎药容器内加水煎煮二次,第一次加水8倍量,煎煮1.5小时,第二次加水6倍量煎煮1小时,合并两次煎煮液,过滤得滤液;
(2)将滤液浓缩成比重为1.35的浸膏,加90%-95%乙醇进行醇沉,回收乙醇并浓缩,在45-50℃下干燥,制得干浸膏;(3)将干浸膏粉碎成细粉,加入乙醇作黏合剂,加入淀粉作填充剂,压制成颗粒剂。
3、本发明药物片剂的制备:
(1)将炮制好的黄苓、黄连、连翘、玄参、板蓝根、马勃、牛蒡子、白僵蚕、升麻、柴胡、陈皮、桔梗、前胡、甘草、薄荷、夏枯草、海藻、昆布放入煎药容器内加水煎煮二次,第一次加水8倍量,煎煮1.5小时,第二次加水6倍量煎煮1小时,合并两次煎煮液,过滤得滤液;
(2)将滤液浓缩成比重为1.35的浸膏,加90%-95%乙醇进行醇沉,回收乙醇并浓缩,在45-50℃下干燥,制得干浸膏;(3)将干浸膏粉碎成细粉,加入辅料制成颗粒,压制成片,每片0.5克。
4、本发明药物蜜丸的制备:
(1)将炮制好的黄苓、黄连、连翘、玄参、板蓝根、马勃、牛蒡子、白僵蚕、升麻、柴胡、陈皮、桔梗、前胡、甘草、薄荷、夏枯草、海藻、昆布混合搅拌均匀,研细粉末过200目细筛;
(2)将蜂蜜炼制成110-115℃的嫩蜜;
(3)将研为细粉的药料按重量1:1的比例加入蜂蜜内混合制坨,再搓条制丸,每丸含纯药1.5克。
本发明药物具有散风清热,消肿解毒的功能,用于治疗腮腺炎见效快、疗效好、不复发。
组方中板蓝根清热、解毒、凉血,为君药,连翘清热、解毒、散结、消肿,牛蒡子消肿解毒、疏散风热二者为臣药;海藻有软坚、消痰、利水、泄热的功能为佐药,甘草润肺、解毒、和中缓急,有调和诸药的功能为使药,与下余诸药是治标,将上述药物组合,使得各药物功效产生协同作用,从而能够有效治疗腮腺炎的复发。
以下通过试验例来进一步阐述本发明药物的有益效果,这些试验包括本发明药物的动物毒性试验和临床疗效观察试验。
[试验例1]本发明药物的动物毒性试验
取西德兔30只,雌雄兼用,体重2.0-2.5k克,分为二组,其中一组为超剂量,另一组为正常量,超剂量组口服胶囊剂、颗粒剂或片剂中的一种剂型为0.2g/kg,正常量组0.1g/kg,采用稀释灌胃法给药,每日二次,连续服用7天,观察给药反应,结果表明家兔活动、饮食正常,药物无不良毒副作用。
[试验例2]本发明药物的临床疗效观察
1、一般资料
收治门诊患者共38例。
2、诊断标准
腮腺炎临床表现有:腮腺局部红肿热痛,化脓期挤压腮腺时腮腺口有脓液流出。血常规白细胞总数增加,中性粒细胞比例明显上升,取腮腺导管流出的脓液进行细菌培养可以明确诊断。
3、治疗方法
选用上述药剂给患者服用,每次服胶囊或颗粒剂或片剂4克,或蜜丸6丸,每日三次,7天一疗程,连续服用二个疗程。
4、疗效评定标准
显效:腮腺炎病灶消除,痊愈。
好转:腮腺炎疼痛症状减轻,红肿消退,逐步恢复。
无效:达不到好转标准者。
5、治疗结果(见下表):
在上述治疗中,用本发明药物治疗腮腺炎患者38例,结果显效35例,显效率为92.10%,好转3例,总有效率为100%。
Claims (3)
1.一种治疗腮腺炎的药物,其特征在于:它是由下列重量范围内的原料药制成:黄芩110-130克、黄连50-70克、连翘140-160克、玄参100-130克、板蓝根250-350克、马勃50-70克、牛蒡子110-130克、白僵蚕80-100克、升麻110-130克、柴胡100-130克、陈皮120-160克、桔梗80-110克、前胡120-160克、甘草80-100克、薄荷120-160克、夏枯草120-160克、海藻115-125克、昆布110-130克。
2.根据权利要求1所述的药物,其中各原料药的用量为:
黄芩120克、黄连60克、连翘150克、玄参120克、板蓝根300克、马勃50克、牛蒡子120克、白僵蚕90克、升麻120克、柴胡120克、陈皮150克、桔梗100克、前胡150克、甘草90克、薄荷150克、夏枯草150克、海藻120克、昆布120克。
3.根据权利要求1或2所述药物的制备方法,其特征在于:它包括下列步骤:
一、备料
(1)黄芩:拣去杂质,除去残茎,用凉水浸润或置开水中稍浸捞出,切片,晒干;
(2)黄连:拣去杂质,洗净泥砂,润透,切片,阴干;
(3)连翘:拣净杂质,搓开,除去枝梗;
(4)玄参:拣净杂质,除去芦头,洗净润透,切片,晾干;
(5)板蓝根:拣净杂质,洗净,润透,切片,晒干;
(6)马勃:除去硬皮,切成方块;
(7)牛蒡子:拣去杂质,筛去泥屑;
(8)白僵蚕:拣去丝毛,洗净灰土,晒干;
(9)升麻:拣去杂质,略泡洗净,捞出,润透,切片,晒干;
(10)柴胡:拣去杂质,除去残茎,洗净泥沙,捞出,润透后及时切片,晒干;
(11)陈皮:取原药材,除去杂质及变黑的果皮,抢水洗净,润软,切丝,晒干或低温干燥,筛去灰屑;
(12)桔梗:拣净杂质,除去芦头,洗净捞出,润透后切片,晒干;
(13)前胡:取原药材,除去杂质,洗净,润透,切薄片,干燥或低温干燥,筛去碎屑;
(14)甘草:取甘草片,加炼熟的蜂蜜与开水少许,拌匀,稍闷,置锅内用文火炒至变深黄色,不粘手为止,取出放凉,每甘草100斤,用炼熟蜂蜜25—30斤;
(15)薄荷:拣净杂质,除去残根,先将叶抖下另放,然后将茎喷洒清水,润透后切段,晒干,再与叶和匀;
(16)夏枯草:取原药材,除去枝梗、叶片及杂质,筛去灰屑;
(17)海藻:拣去杂质,用水略漂,稍晾,切段,晒干;
(18)昆布:拣去杂质,用水漂净,切成宽丝,晾干;
二、制备
(1)本发明药物胶囊的制备:
①将炮制好的黄苓、黄连、连翘、玄参、板蓝根、马勃、牛蒡子、白僵蚕、升麻、柴胡、陈皮、桔梗、前胡、甘草、薄荷、夏枯草、海藻、昆布放入煎药容器内加水煎煮二次,第一次加水8倍量,煎煮1.5小时,第二次加水6倍量煎煮1小时,合并两次煎煮液,过滤得滤液;②将滤液浓缩成比重为1.35的浸膏,加90%-95%乙醇进行醇沉,回收乙醇并浓缩,在45-50℃下干燥,制得干浸膏;(3)将干浸膏粉碎成粉,装入胶囊,每粒0.5克;
(2)本发明药物颗粒剂的制备:
①将炮制好的黄苓、黄连、连翘、玄参、板蓝根、马勃、牛蒡子、白僵蚕、升麻、柴胡、陈皮、桔梗、前胡、甘草、薄荷、夏枯草、海藻、昆布放入煎药容器内加水煎煮二次,第一次加水8倍量,煎煮1.5小时,第二次加水6倍量煎煮1小时,合并两次煎煮液,过滤得滤液;
②将滤液浓缩成比重为1.35的浸膏,加90%-95%乙醇进行醇沉,回收乙醇并浓缩,在45-50℃下干燥,制得干浸膏;(3)将干浸膏粉碎成细粉,加入乙醇作黏合剂,加入淀粉作填充剂,压制成颗粒剂;
(3)本发明药物片剂的制备:
①将炮制好的黄苓、黄连、连翘、玄参、板蓝根、马勃、牛蒡子、白僵蚕、升麻、柴胡、陈皮、桔梗、前胡、甘草、薄荷、夏枯草、海藻、昆布放入煎药容器内加水煎煮二次,第一次加水8倍量,煎煮1.5小时,第二次加水6倍量煎煮1小时,合并两次煎煮液,过滤得滤液;
②将滤液浓缩成比重为1.35的浸膏,加90%-95%乙醇进行醇沉,回收乙醇并浓缩,在45-50℃下干燥,制得干浸膏;(3)将干浸膏粉碎成细粉,加入辅料制成颗粒,压制成片,每片0.5克;
(4)本发明药物蜜丸的制备:
①将炮制好的黄苓、黄连、连翘、玄参、板蓝根、马勃、牛蒡子、白僵蚕、升麻、柴胡、陈皮、桔梗、前胡、甘草、薄荷、夏枯草、海藻、昆布混合搅拌均匀,研细粉末过200目细筛;
②将蜂蜜炼制成110-115℃的嫩蜜;
③将研为细粉的药料按重量1:1的比例加入蜂蜜内混合制坨,再搓条制丸,每丸含纯药1.5克。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510572744.5A CN105168554A (zh) | 2015-09-10 | 2015-09-10 | 一种治疗腮腺炎的药物及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510572744.5A CN105168554A (zh) | 2015-09-10 | 2015-09-10 | 一种治疗腮腺炎的药物及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105168554A true CN105168554A (zh) | 2015-12-23 |
Family
ID=54891309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510572744.5A Pending CN105168554A (zh) | 2015-09-10 | 2015-09-10 | 一种治疗腮腺炎的药物及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105168554A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107715009A (zh) * | 2017-12-14 | 2018-02-23 | 阜阳市平衡医疗保健器械有限公司 | 一种治疗流行性腮腺炎的药物及其制备方法 |
| CN108125912A (zh) * | 2017-12-11 | 2018-06-08 | 河南明珍方医药科技有限公司 | 普济消毒颗粒的制备方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103041030A (zh) * | 2013-01-18 | 2013-04-17 | 成都中医药大学 | 一种治疗大头瘟的药物组合物及其制备方法和用途 |
| CN103070974A (zh) * | 2013-02-17 | 2013-05-01 | 成都科创佳思科技有限公司 | 一种治疗流行性腮腺炎的中药组合物 |
-
2015
- 2015-09-10 CN CN201510572744.5A patent/CN105168554A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103041030A (zh) * | 2013-01-18 | 2013-04-17 | 成都中医药大学 | 一种治疗大头瘟的药物组合物及其制备方法和用途 |
| CN103070974A (zh) * | 2013-02-17 | 2013-05-01 | 成都科创佳思科技有限公司 | 一种治疗流行性腮腺炎的中药组合物 |
Non-Patent Citations (1)
| Title |
|---|
| 胡自然: "普济消毒饮加减治疗儿童流行性腮腺炎35例疗效观察", 《中国现代药物应用》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108125912A (zh) * | 2017-12-11 | 2018-06-08 | 河南明珍方医药科技有限公司 | 普济消毒颗粒的制备方法 |
| CN107715009A (zh) * | 2017-12-14 | 2018-02-23 | 阜阳市平衡医疗保健器械有限公司 | 一种治疗流行性腮腺炎的药物及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103610978B (zh) | 一种治疗失眠的药物及其制备方法 | |
| CN103169903B (zh) | 一种治疗小儿支气管炎的中药制剂及其制备方法 | |
| CN103127433B (zh) | 一种治疗肺癌的中药及其制备方法 | |
| CN103550696B (zh) | 一种治疗肺癌的药物 | |
| CN104043057A (zh) | 一种治疗淋巴癌的中药组合物 | |
| CN103638361B (zh) | 一种治疗咳嗽的药物及其制备方法 | |
| CN102805843A (zh) | 一种治疗胃痛的药物及其制备方法 | |
| CN104984267A (zh) | 一种治疗肺癌的中药组合物 | |
| CN103463449A (zh) | 一种用于治疗痔疮的中药组合物及其制备方法和其应用 | |
| CN103638399A (zh) | 一种治疗小儿流行性腮腺炎的药物及其制备方法 | |
| CN103638346B (zh) | 一种治疗急性支气管炎的药物及其制备方法 | |
| CN105168554A (zh) | 一种治疗腮腺炎的药物及其制备方法 | |
| CN105434952A (zh) | 一种治疗丹痧的药物及其制备方法 | |
| CN105079676A (zh) | 一种治疗脂肪肝的药物及其制备方法 | |
| CN105012669A (zh) | 一种治疗上消化道出血的药物及其制备方法 | |
| CN104800510A (zh) | 一种治疗胃癌的中药组合物 | |
| CN105031102A (zh) | 一种治疗高血压的药物及其制备方法 | |
| CN105521332A (zh) | 治疗肛裂的中药组合物及其制备方法和应用 | |
| CN104771660A (zh) | 治疗胃癌的中药剂及制备方法 | |
| CN105327182A (zh) | 一种治疗儿童百日咳的药物及其制备方法 | |
| CN103611137B (zh) | 一种治疗支气管扩张咯血的药物及其制备方法 | |
| CN103330861B (zh) | 一种治疗霍乱的药物及其制备方法 | |
| CN102526625B (zh) | 一种治疗乙型肝炎的药物及其制备方法 | |
| CN106511803A (zh) | 一种治疗鼻出血的药物及其制备方法 | |
| CN105963586A (zh) | 一种治疗肺脓肿的药物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151223 |